<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Mismatch Repair-Deficient Crypt Foci in Lynch Syndrome -Molecular Alterations and Association with Clinical Parameters</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-03-27">March 27, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Laura</forename><surname>Staffa</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Applied Tumour Biology</orgName>
								<orgName type="department" key="dep2">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 224</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fabian</forename><surname>Echterdiek</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Applied Tumour Biology</orgName>
								<orgName type="department" key="dep2">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 224</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nina</forename><surname>Nelius</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Applied Tumour Biology</orgName>
								<orgName type="department" key="dep2">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 224</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Axel</forename><surname>Benner</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Biostatistics</orgName>
								<orgName type="institution">DKFZ (German Cancer Research Center)</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 280</addrLine>
									<settlement>Heidelberg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wiebke</forename><surname>Werft</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Biostatistics</orgName>
								<orgName type="institution">DKFZ (German Cancer Research Center)</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 280</addrLine>
									<settlement>Heidelberg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bernd</forename><surname>Lahrmann</surname></persName>
							<affiliation key="aff3">
								<orgName type="institution">Hamamatsu Tissue Imaging and Analysis (TIGA) Center</orgName>
								<address>
									<settlement>Bioquant, Heidelberg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Niels</forename><surname>Grabe</surname></persName>
							<affiliation key="aff3">
								<orgName type="institution">Hamamatsu Tissue Imaging and Analysis (TIGA) Center</orgName>
								<address>
									<settlement>Bioquant, Heidelberg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Schneider</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of General, Visceral and Accident Surgery</orgName>
								<orgName type="institution">University Hospital Heidelberg</orgName>
								<address>
									<settlement>Heidelberg Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mirjam</forename><surname>Tariverdian</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of General, Visceral and Accident Surgery</orgName>
								<orgName type="institution">University Hospital Heidelberg</orgName>
								<address>
									<settlement>Heidelberg Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Magnus</forename><surname>Von Knebel Doeberitz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hendrik</forename><surname>Bläker</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Applied Tumour Biology</orgName>
								<orgName type="department" key="dep2">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 224</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of General Pathology</orgName>
								<orgName type="institution">University Hospital Charité</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Matthias</forename><surname>Kloor</surname></persName>
							<email>matthias.kloor@med.uni-heidelberg.de</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Applied Tumour Biology</orgName>
								<orgName type="department" key="dep2">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 224</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">DKFZ (German Cancer Research Center</orgName>
								<orgName type="laboratory">Clinical Cooperation Unit Applied Tumour Biology</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 280</addrLine>
									<settlement>Heidelberg, Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">University of Navarra</orgName>
								<address>
									<country key="ES">SPAIN</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Mismatch Repair-Deficient Crypt Foci in Lynch Syndrome -Molecular Alterations and Association with Clinical Parameters</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-03-27">March 27, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">D9084F24298970B7215856A5D8289E87</idno>
					<idno type="DOI">10.1371/journal.pone.0121980</idno>
					<note type="submission">Received: November 28, 2014 Accepted: February 5, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:17+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Lynch syndrome is caused by germline mutations of DNA mismatch repair (MMR) genes, most frequently MLH1 and MSH2.</s><s>Recently, MMR-deficient crypt foci (MMR-DCF) have been identified as a novel lesion which occurs at high frequency in the intestinal mucosa from Lynch syndrome mutation carriers, but very rarely progress to cancer.</s><s>To shed light on molecular alterations and clinical associations of MMR-DCF, we systematically searched the intestinal mucosa from Lynch syndrome patients for MMR-DCF by immunohistochemistry.</s><s>The identified lesions were characterised for alterations in microsatellite-bearing genes with proven or suspected role in malignant transformation.</s><s>We demonstrate that the prevalence of MMR-DCF (mean 0.84 MMR-DCF per 1 cm 2 mucosa in the colorectum of Lynch syndrome patients) was significantly associated with patients' age, but not with patients' gender.</s><s>No MMR-DCF were detectable in the mucosa of patients with sporadic MSI-H colorectal cancer (n = 12).</s><s>Microsatellite instability of at least one tested marker was detected in 89% of the MMR-DCF examined, indicating an immediate onset of microsatellite instability after MMR gene inactivation.</s><s>Coding microsatellite mutations were most frequent in the genes HT001 (ASTE1) with 33%, followed by AIM2 (17%) and BAX (10%).</s><s>Though MMR deficiency alone appears to be insufficient for malignant transformation, it leads to measurable microsatellite instability even in single MMR-deficient crypts.</s><s>Our data indicate for the first time that the frequency of MMR-DCF increases with patients' age.</s><s>Similar patterns of coding microsatellite instability in MMR-DCF and MMR-deficient cancers suggest that certain combinations of coding microsatellite mutations, including mutations of the HT001, AIM2 and BAX gene, may contribute to the progression of MMR-deficient lesions into MMRdeficient cancers.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Lynch syndrome, occurring with an estimated allele frequency of up to 1:350, is one of the most common inherited cancer syndromes <ref type="bibr" target="#b0">[1]</ref> and clinically often referred to as hereditary non-polyposis colorectal cancer (HNPCC) <ref type="bibr" target="#b1">[2]</ref>.</s><s>Lynch syndrome mutation carriers have a lifetime risk of about 40% to 80% to develop colorectal cancer <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b3">4]</ref>.</s></p><p><s>Tumorigenesis in Lynch syndrome-associated malignancies is caused by deficiency of one of the DNA MMR genes, such as MLH1, MSH2, PMS2 and MSH6 <ref type="bibr" target="#b4">[5]</ref>.</s><s>Carriers of a germline mutation in one allele of the respective MMR gene acquire a second somatic mutation that inactivates the remaining functional allele of the MMR gene, following the classical two-hit hypothesis <ref type="bibr" target="#b5">[6]</ref>.</s><s>Inactivation of MMR genes consequently leads to the loss of MMR protein expression in tumour cells and to an MSI-H phenotype.</s><s>This phenomenon can be detected by immunohistochemistry <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8]</ref> and thus point to the appropriate MMR gene for mutation analysis.</s></p><p><s>A feature characteristic of Lynch syndrome is the lack of polyposis, which is in sharp contrast to other inherited colorectal cancer-predisposing syndromes like the familial adenomatous polyposis <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref>.</s><s>Recently, MMR-DCF have been described as a non-polypous morphologic correlate of somatic MMR gene inactivation in Lynch syndrome <ref type="bibr" target="#b11">[12]</ref>.</s><s>MMR-DCF occur at thousands in otherwise phenotypically normal intestinal mucosa of Lynch syndrome mutation carriers <ref type="bibr" target="#b11">[12]</ref>.</s><s>This is in contrast to the limited penetrance of Lynch syndrome and indicates that MMR-DCF only rarely progress to cancer.</s><s>However, the natural history of MMR-DCF, as well as their association with clinical parameters and their molecular characteristics, are completely unknown.</s></p><p><s>At advanced stages of tumour progression, MMR deficiency can promote tumour development through mutations affecting microsatellites located in gene-encoding regions that are essential for growth regulation, differentiation or apoptosis <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref>.</s><s>Certain coding microsatellite-bearing target genes have been proven or suspected to have functional relevance in MSI-H colorectal cancer.</s><s>These include ACVR2 (activin receptor type 2), TAF1B (TATA box binding protein-associated factor) and HT001, also known as ASTE1 (asteroid homolog 1), which show mutation rates of more than 80% in MSI-H colorectal cancer <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref>.</s><s>Also AIM2 (absent in melanoma 2), and the pro-apoptotic BAX (BCL2-associated X protein) are inactivated by coding microsatellite mutations in the majority of MSI-H colorectal cancer <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref>.</s><s>The most prominent example of a functionally relevant target gene in MSI-H colorectal cancer, is the TGFBR2 (transforming growth factor receptor type 2) gene <ref type="bibr" target="#b21">[22]</ref> which bears a coding microsatellite of ten adenosine residues frequently targeted by MMR gene inactivation.</s></p><p><s>In the present study, we aimed to characterise the clinical and molecular characteristics of MMR-DCF as possible cancer precursor lesions in Lynch syndrome.</s><s>To that end, we correlated the occurrence of MMR-DCF with clinical parameters like patients' age, gender, and MMR gene germline mutation.</s><s>In order to identify the consequences of MMR deficiency with potential functional significance in MMR-DCF, we focused on potential driver mutations in selected coding microsatellite-bearing target genes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Samples of patient cohorts and controls</head><p><s>Paraffin-embedded archival tissues from small and large bowel (270 paraffin blocks) from Lynch syndrome patients (n = 34) operated for colorectal cancer were retrieved from the archive of the Institute of Pathology University Hospital Heidelberg, Heidelberg, Germany.</s><s>Resections had been performed between 1999 and 2011.</s><s>Non-tumorous mucosa from the resection margins and from tumour-adjacent non-neoplastic tissue was analysed for changes in MMR protein expression (MLH1, MSH2, and MSH6).</s><s>Of the 34 Lynch syndrome patients, 19 showed a MLH1 mutation, 14 a MSH2 mutation and one patient presented with a MSH6 mutation.</s><s>In addition non-tumorous mucosa was analysed from patients with sporadic MMRdeficient cancers caused by MLH1 promoter methylation (n = 12).</s><s>Moreover, control staining with an antibody specific for an MMR protein not affected by a germline mutation was performed in 5 of the Lynch syndrome patients and one MSS control patient.</s><s>For correlation analysis with clinical parameters, the cohort was enlarged by including 10 patients (LS 1-10; 4 with MLH1 and 6 with a MSH2 mutation) and 9 controls (patients with MMR-proficient colorectal cancer) published in our previous study <ref type="bibr" target="#b11">[12]</ref>.</s><s>The study was approved by the Ethics Committee of the University Hospital Heidelberg.</s><s>All patients provided informed and written consent for participation in the study of the German HNPCC Consortium.</s></p><p><s>All blocks were cut into ten serial sections of 2 μm each.</s><s>The fifth slide was chosen for MMR protein immunohistochemistry, three adjacent slides were used for manual microdissection and four slides were stained with antibodies against immune cell markers.</s><s>These slides together with the fifth one were scanned using the Nanozoomer 2.0-HT Scansystem at the Hamamatsu TIGA Center (BioQuant, Heidelberg) for analysis and later also used for microdissection.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistochemistry and length measurement</head><p><s>Immunohistochemistry was performed on 2 μm paraffin sections by using monoclonal antibodies specific for MLH1 (clone G168-15, dilution 1:25, BD Pharmingen, Heidelberg, Germany), MSH2 (clone FE11, dilution 1:200, Calbiochem, Darmstadt, Germany) or MSH6 (clone44, dilution 1:50, Cell Marque, Rocklin, USA) for detecting loss of MMR protein as described previously <ref type="bibr" target="#b11">[12]</ref>.</s><s>An immunoperoxidase method was used to visualise the antibodies by labelling them with a chromogen (3-amino-9-ethylcarbazole, Dako, Glostrup, Denmark).</s><s>The amount of mucosal length and surface analysed was calculated as described previously <ref type="bibr" target="#b11">[12]</ref>.</s></p><p><s>For immunohistochemical staining of immune cells in the vicinity of MMR-DCF the following antibodies were used: CD4 (clone RPA-T4, dilution 1:50, BD Pharmingen, Heidelberg, Germany), CD8 (clone 4B11, dilution 1:50, Novocastra, Wetzlar, Germany) and FoxP3 (clone 236A/E7, dilution 1:50, eBioscience, Frankfurt, Germany).</s></p><p><s>Immune cell infiltration was qualitatively assessed by two independent observers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>PCR and direct microdissection</head><p><s>Nine microsatellite markers were examined in MMR-DCF and normal MMR-proficient intestinal crypts by PCR using Platinum Taq Polymerase (Invitrogen, Life technologies, Darmstadt, Germany).</s><s>For each PCR, the master mix was prepared as follows: 2.5 μl of 10 x buffer, 0.75 μl of 50 mM MgCl 2 , 5 μl of 1.25 mM dNTPs, 0.2 μl of Taq polymerase, two or three primer pairs in different dilutions (see below) and RNAse-free water ad 25 μl.</s><s>Template was added to the PCR mastermix by direct manual microdissection from immunohistochemically or haematoxylin/eosin-stained sections of MMR-DCF and control crypts.</s></p><p><s>To increase the number of evaluated genes bearing coding or non-coding microsatellites, different duplex or triplex PCRs were performed using the following primer combinations: Approach 1: AIM2 (1 μl per primer), ACVR2 (3 μl); Approach 2: BAX (1 μl), HT001 (2 μl); Approach 3: TGFBR2 (1 μl), TAF1B (1 μl); Approach 4: BAT25 (0.7 μl), BAT26 (1 μl) and CAT25 (1.3 μl).</s><s>For approaches 1-3 cycling conditions were as follows: 5 min at 94°C; 40 cycles: 52 s at 94°C, 66 s at 56°C, 44 s at 72°C; 6 min at 72°C.</s><s>For approach 4, cycling conditions were identical except for the annealing temperature (55°C).</s><s>Coding microsatellites located within a gene are referred to by the name of the gene throughout the manuscript.</s><s>PCR products were separated on an ABI3100 sequencer (Applied Biosystems, Darmstadt, Germany), and fragment lengths were identified with the GeneMapper software 5 (Release 5.0, Applied Biosystems, Darmstadt, Germany).</s><s>As a control for the molecular analyses, an additional set of 7 MSS colorectal cancer patients was included in the microdissection approach</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Since the surface area and the crypt numbers were estimated as functions of mucosal length, the statistical analysis of the number of MMR-DCF was performed with respect to the assessed mucosal lengths only.</s><s>Based on the assumption that the number of MMR-DCF follows a Poisson distribution, a Poisson regression model was applied to analyse the occurrence of crypt foci with respect to mucosal length, tumour localisation, germline mutation, age and gender.</s><s>Models were checked for overdispersion and zero inflation.</s><s>Expected counts and incident rate ratios together with their corresponding 95% confidence intervals (95% CIs) were computed to illustrate the results.</s><s>Fisher's exact test was used to compare mutation frequencies of the analysed microsatellite markers in MMR-DCF and controls.</s><s>For all statistical tests undertaken, a result was regarded significant with a p-value &lt;0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Frequency and clinical distribution</head><p><s>In total, MMR protein immunohistochemistry was performed in 714 cm of mucosa (626 cm large bowel, 88 cm small bowel) from carriers of a Lynch syndrome mutation and 144 cm (129 cm large bowel, 15 cm small bowel) from patients without a germline mutation in the respective MMR gene, including 62 cm of mucosa (49 cm large bowel, 13 cm small bowel) from patients with sporadic MSI-H colorectal cancer.</s><s>This corresponds to the following surface areas: 24.9 cm 2 mucosa from Lynch syndrome mutation carriers (22.5 cm 2 large bowel, 2.4 cm 2 small bowel) and 5.1 cm 2 from patients without an MMR gene germline mutation (4.7 cm 2 large bowel, 0.4 cm 2 small bowel), including 2.2 cm 2 from sporadic MSI-H colorectal cancer patients (1.8 cm 2 large bowel, 0.4 cm 2 small bowel).</s></p><p><s>In sections from Lynch syndrome patients, immunohistochemistry for MLH1, MSH2 and MSH6 revealed 21 crypt foci lacking the expression of the respective MMR protein (Fig. <ref type="figure" target="#fig_0">1A</ref>).</s><s>The MMR-DCF always showed loss of the MMR protein corresponding to the respective MMR gene germline mutation of the patient.</s><s>MMR-DCF were identified in the large bowel mucosa of 9 patients and in the small bowel mucosa of 2 patients.</s><s>Among patients who did not display any MMR-DCF, the maximal length analysed was 28 cm (approximately 1 cm 2 ); the minimal length analysed in MMR-DCF-positive patients was 6 cm (0.17 cm 2 ) in the small bowel and 8 cm in the colon (0.29 cm 2 ).</s></p><p><s>Overall, the frequency of MMR-DCF in Lynch syndrome mutation carriers was 0.84 foci/cm 2 (19 foci/22.5 cm 2 ) in the colon and 0.83 foci/cm 2 (2 foci/2.4</s><s>cm 2 ) in the small bowel.</s><s>No significant difference of MMR-DCF frequency was observed between MLH1 and MSH2 germline mutation carriers.</s><s>No MMR-DCF were found in 62 cm (approximately 2.2 cm 2 ) mucosa of all 12 patients with sporadic MLH1-hypermethylated MSI-H colorectal cancer patients or in 82 cm (approximately 3 cm 2 ) of the control patients without germline mutations of the respective MMR gene.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association with clinical parameters</head><p><s>As a next step, a potential correlation of MMR-DCF in the colorectum with tumour localisation, gender and age was addressed.</s><s>MMR-DCF were significantly more frequent in patients with cancer of the distal colorectum (left colonic flexure or more distal, n = 7) compared to patients with proximal colon cancer (n = 22) (2.38 MMR-DCF per 50 cm [1.8 cm 2 ] in the distal colorectum, 95% CI 0.57-4.19,</s><s>vs. 0.55 MMR-DCF per 50 cm [1.8 cm 2 ] in the proximal colon, 95% CI 0.19-0.92,</s><s>p = 0.008).</s><s>Patients from both groups, proximal and distal tumour localisation, did not significantly vary concerning parameters such as age and gender (proximal tumour localisation, median age: 44 years, 23% female; distal tumour localisation, median age: 45 years, 14% female).</s></p><p><s>To examine the correlation between prevalence of colorectal MMR-DCF and age or gender, combined analyses encompassing previously published patients <ref type="bibr" target="#b11">[12]</ref> were performed.</s><s>There was no significant association of MMR-DCF prevalence with gender (1.05 MMR-DCF per 50 cm [1.8 cm 2 ] in females, 95% CI 0.19-1.92,</s><s>vs. 0.96 MMR-DCF per 50 cm [1.8 cm 2 ] in males, 95% CI 0.57-1.35,</s><s>p = 0.85).</s><s>However, the prevalence of colorectal MMR-DCF was significantly related to the age of the patient at the time of the operation (p&lt;0.001).</s><s>Based on the results of the Poisson regression model, the estimated incident rate ratio of colorectal MMR-DCF was 1.75 (95% CI 1.30-2.35)</s><s>for a change of age at operation of 10 years.</s><s>This corresponds to a number of predicted MMR-DCF per 50 cm (1.8 cm 2 ) mucosa of 0.59 (95% CI 0.27-0.90)</s><s>at an age of 40, and 1.03 (95% CI 0.64-1.42)</s><s>per 50 cm (1.8 cm 2 ) at an age of 50, respectively (Fig. <ref type="figure" target="#fig_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Morphology</head><p><s>To obtain larger amounts of DNA and more MMR-DCF for morphologic and molecular analysis, paraffin blocks from five of the patients that had revealed MMR-DCF in the first round of staining were resectioned.</s><s>Using this method, six novel, independent MMR-DCF were identified and included in the molecular analysis.</s><s>The crypt foci detected in our study displayed a varying size from one to nine crypts.</s><s>Seven of the now 27 MMR-DCF (4/15 monocryptic, 1/9 oligocryptic and 2/3 polycryptic) presented with dysplastic changes but none showed a polypous or adenomatous appearance.</s><s>The remaining 20 foci were morphologically undistinguishable from their neighbouring crypts except for their absence of MMR protein expression.</s><s>Morphological characterisation of MMR-DCF-adjacent mucosal areas after haematoxylin/ eosin and immunohistochemistry staining specific for T cell markers including CD4, CD8 and FOXP3 did not reveal signs of an altered immune infiltration in or around any of the MMR-DCF assessed (S4 Fig. <ref type="figure">)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Molecular alterations in MMR-DCF</head><p><s>For molecular characterisation of the detected MMR-DCF, we analysed three non-coding and six coding microsatellite markers located in genes proven or suspected to be relevant for tumour formation.</s><s>Mutation patterns in MMR-DCF were compared to MMR-proficient crypts from Lynch syndrome mutation carriers or MSS colorectal cancer control patients.</s></p><p><s>The general comparison of microsatellite mutation frequency revealed a significantly higher number of mutation events in MMR-DCF than in MMR-proficient crypts, when all markers were considered: MMR-DCF: 44 out of 186, 23.7%; MMR-proficient crypts from Lynch syndrome mutation carriers: 34 out of 814, 4.2%; MMR-proficient crypts from MSS colorectal cancer patients: 5 out of 173, 2.9%; p&lt;0.001.</s></p><p><s>The mutation frequency observed in MMR-DCF was highest for the three non-coding microsatellite markers BAT25, BAT26, and CAT25, which showed a mutant pattern in 36%, 57%, and 60% of the analysed MMR-DCF, respectively (Fig. <ref type="figure" target="#fig_0">1B</ref>).</s><s>No significant difference was observed between the three markers.</s></p><p><s>Among coding microsatellites, the observed mutation frequency ranged between 0% and 33% for the six analysed markers located in the coding regions of the genes AIM2, ACVR2, BAX, HT001, TAF1B and TGFBR2 (Fig. <ref type="figure" target="#fig_0">1C</ref>).</s><s>Mutations were detected in 5 out of 6 markers tested, but were absent in TGFBR2.</s><s>Mutation frequency was highest for the HT001 microsatellite (33%) followed by AIM2 (17%) and BAX (10%).</s><s>For these three markers the difference of mutation prevalence between MMR-DCF and MMR-proficient crypts was significant: HT001: 7/21 (33%) vs. 0/72 (0%), p&lt;0.0001;</s><s>AIM2: 4/24 (17%) vs. 2/85 (2%), p = 0.0206; BAX: 2/21 (10%) vs. 0/75 (0%), p = 0.0461.</s><s>Mutation frequency of non-coding and coding microsatellites is displayed in Table <ref type="table">1</ref>.</s></p><p><s>From 23 crypt foci evaluable for MSI at non-coding markers, 20 (87%) presented with mutations affecting at least one of the markers BAT25, BAT26, or CAT25.</s><s>MSI affecting coding markers was detected in 10 out of 25 (40%) of MMR-DCF.</s><s>The distribution of coding and non-coding marker mutation frequency per individual crypt is illustrated in Fig. <ref type="figure" target="#fig_2">3</ref>. MMR-DCF consisting of more than one crypt tended to show a higher frequency of mutations than singlecrypt MMR-DCF, though statistical significance was lacking (23/100 vs. 21/130, p = 0.24, Fisher's exact test).</s><s>Table <ref type="table">1</ref>.</s><s>Overview of mutation frequencies of all markers tested.</s><s>Absolute numbers of crypts examined are followed by mutation percentages.</s><s>MMR-proficient crypts from Lynch syndrome patients and MSS colorectal cancer patients were evaluated as controls.</s><s>P-values were calculated concerning results of MMR-DCF versus Lynch syndrome crypts.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MMR-DCF</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Regional diversity of MMR-DCF</head><p><s>To examine the mutational events taking place during the clonal expansion of MMR-deficient crypts, we examined regional diversity of mutations in MMR-DCF by separately analysing six regions of one MLH1-negative extended crypt focus from patient LS 4 (extended set).</s><s>Mutations were only detected in HT001 and AIM2 from all the coding markers, and HT001 presented with the most heterogeneous mutation pattern.</s><s>For the non-coding markers, there were mutations displayed in almost every region of the crypt focus, also differing in the mutation pattern (S3 Fig. <ref type="figure">)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Comparison of the mutation frequency in MMR-DCF and MSI-H colorectal cancer</head><p><s>In order to compare the mutation frequency of selected microsatellite markers between MMR-DCF and clinically manifest MSI-H adenomas and carcinomas, data for MSI-H colorectal adenoma and cancer were retrieved from SelTarbase <ref type="bibr" target="#b14">[15]</ref>.</s><s>In addition, cancer specimens obtained from the study patients were analysed.</s><s>As shown in Fig. <ref type="figure" target="#fig_3">4</ref>, the mutation prevalence of the three non-coding microsatellite markers BAT25, BAT26 and CAT25 in MMR-DCF followed the same tendency as observed in MSI-H colorectal cancer.</s><s>CAT25 presented with the highest mutation rate, followed by BAT26 and BAT25 in both groups.</s><s>Of the six coding microsatellite markers, HT001 presented with the highest mutation frequency in both groups.</s><s>In contrast, the most pronounced discrepancies were observed for TAF1B and TGFBR2 (Fig. <ref type="figure" target="#fig_3">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In the present study, we focused on molecular alterations occurring in MMR-DCF, and their relation to clinical or histopathological parameters.</s><s>Our observations confirm the previously described prevalence of approximately one MMR-DCF per 1 cm 2 of mucosa <ref type="bibr" target="#b11">[12]</ref>.</s><s>For the first time, patients with sporadic MSI-H colorectal cancer with MLH1 promoter hypermethylation were analysed for the presence of MMR-DCF.</s><s>No MMR-DCF were observed in these patients, including the directly tumour-adjacent mucosa, which could be assessed from all patients.</s><s>The lack of MMR-DCF in patients with sporadic MSI-H colorectal cancer may result from a distinct pathway of tumour development that, in contrast to abrupt loss of MLH1 in Lynch syndrome-associated lesions, encompasses a gradual decrease of MLH1 protein expression due to increasing epigenetic changes <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b23">24]</ref>.</s><s>Our observations suggest that the occurrence of MMR-DCF is restricted to Lynch syndrome mutation carriers and closely associated with the presence of MMR gene germline mutations.</s><s>It is therefore expected that patients with sporadic MSI-H colorectal cancers that develop cancer as a consequence of two somatic MMR gene mutations <ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref> will not harbour MMR-deficient crypt foci in the colon mucosa, similar to our observation in patients with MLH1-hypermethylated cancers.</s><s>However, so far no data are available to confirm this assumption.</s><s>A strong correlation was observed between patient's age at operation and the prevalence of MMR-DCF (p&lt;0.001).</s><s>This finding indicates an increasing frequency of MMR-DCF in the mucosa from Lynch syndrome mutation carriers with increasing patients' age.</s><s>It is not clear, though, whether this results from accumulation and persistence of all MMR-DCF formed during life, or whether it reflects a higher rate of lesion formation than lesion elimination.</s><s>An additional factor that might contribute to the accumulation of MMR-DCF in elderly people could be an increasing susceptibility of existing cells towards developing a mutation due to genomic instability <ref type="bibr" target="#b28">[29]</ref>.</s><s>This question cannot be resolved on the basis of the present study, because the cross-sectional study design does not allow any conclusions on the turnover of MMR-DCF.</s></p><p><s>In Lynch syndrome patients, colorectal cancer predominantly develops in the proximal colon <ref type="bibr" target="#b8">[9]</ref>.</s><s>However, a higher frequency of MMR-DCF was observed in Lynch syndrome patients with distal colorectal cancer localisation.</s><s>This observation may suggest that in Lynch syndrome patients with distal colorectal carcinoma, unidentified factors affecting the carcinogenesis may also promote the development of MMR-DCF.</s><s>A potential association between the number of MMR-DCF and the exposure towards DNA-damaging substances is in fact suggested by a significant increase of mismatch repair-deficient crypts upon temozolomide treatment in a mouse model of Lynch syndrome <ref type="bibr" target="#b29">[30]</ref>.</s><s>The localisation of colorectal cancer to the proximal or distal colorectum in our study was not related to patients' age and gender, excluding these parameters as potential influencing factors.</s></p><p><s>No significant difference with regard to MMR-DCF prevalence was observed between men and women.</s><s>Accordingly, we did not observe any evidence that a difference of MMR-DCF incidence may be responsible for the higher estimated colorectal cancer risk of male compared to female Lynch syndrome mutation carriers <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b31">32]</ref>.</s><s>Similarly, MMR-DCF prevalence was identical between MLH1 and MSH2 mutation carriers, suggesting that the gene affected by germline mutation is not a predictor of MMR-DCF formation.</s></p><p><s>Immune surveillance may contribute to the recognition of MMR-deficient cells by cytotoxic T cells, potentially following the generation of MMR deficiency-induced frameshift peptide antigens <ref type="bibr" target="#b32">[33,</ref><ref type="bibr" target="#b33">34]</ref>.</s><s>However, morphological characterisation of MMR-DCF-adjacent mucosal areas after haematoxylin/eosin and immunohistochemistry staining specific for T cell markers did not reveal significant alterations of immune infiltration in or around any of the MMR-DCF assessed (S4 Fig. <ref type="figure">)</ref>.</s><s>These results indicate that increased immune cell infiltration was not a general phenomenon in the vicinity of MMR-DCF.</s><s>However, the lack of increased immune infiltration in paraffin-embedded tissue sections does not preclude a functionally relevant, specific local immune activation.</s><s>One also has to take into account that immunologic elimination of crypt foci may take place in a very short time compared to the persistence of MMR-DCF and thereby escape visual detection.</s><s>In fact, an enhanced density of mucosal lymphocytes has recently been described in one MMR-deficient crypt focus <ref type="bibr" target="#b34">[35]</ref>.</s></p><p><s>The possibility of examining DNA from individual MMR-deficient crypts opens a window towards assessing the initial molecular changes occurring after loss of MMR function.</s><s>Mutation analyses in frame of our previous study had already revealed mutations affecting large, non-coding microsatellite markers, which are highly prone to insertion/deletion mutations in the context of MMR deficiency, in the majority of MMR-DCF <ref type="bibr" target="#b11">[12]</ref>.</s><s>In the present study, the molecular examination of MMR-DCF was largely extended.</s><s>For the first time, single-crypt MMR-DCF were examined for molecular alterations.</s><s>Our results demonstrate mutations of the three non-coding microsatellite markers BAT25, BAT26, and CAT25 in 40-60% of the MMR-DCF.</s><s>In total, 87% of all MMR-DCFs showed a mutation in at least one of the MSI markers, indicating that the loss of MMR protein expression has immediate functional consequences, already in small and mono-cryptic MMR-DCF.</s><s>Moreover, they underline the suitability of the markers BAT25, BAT26, and CAT25 for the detection of the earliest stages of MMR deficiency in the colorectum.</s></p><p><s>For the first time, mutations of several coding microsatellites could be assessed simultaneously in MMR-DCF.</s><s>Five of the six coding microsatellites assessed in this study displayed mutations in MMR-DCF (AIM2, ACVR2, BAX, HT001, and TAF1B).</s><s>The highest mutation frequency (33%) in the present study was detected for HT001, followed by AIM2 and BAX.</s><s>The observation of HT001 mutations in one third of the analysed MMR-DCF may be compatible with a potential relevance of the respective gene.</s><s>A potential tumour-suppressive function of HT001 is further supported by the high mutation frequency in MSI-H colorectal and endometrial cancer <ref type="bibr" target="#b17">[18]</ref>.</s><s>In general, the comparison of coding microsatellite mutation frequencies follow a similar trend in MMR-DCF compared to corresponding MSI-H cancers from the same patients and to published data for colorectal adenomas and carcinomas <ref type="bibr" target="#b14">[15]</ref>.</s><s>The observed regional heterogeneity in one larger crypt focus (S3 Fig. <ref type="figure">)</ref> suggests that MMR-DCF represent a novel model lesion for studying molecular evolution in Lynch syndrome <ref type="bibr" target="#b35">[36,</ref><ref type="bibr" target="#b36">37]</ref>, and early events associated with initiation and progression of solid neoplasia in general.</s></p><p><s>The comparatively high prevalence of HT001 and AIM2 mutations in MMR-DCF is also interesting with regard to frameshift peptide vaccination approaches, which are currently evaluated in MSI-H colorectal cancer patients.</s><s>The Micoryx vaccine (clinicaltrials.gov,</s><s>NCT01461148) encompasses antigens, which result from mutations of HT001 and AIM2.</s><s>Consequently, frameshift peptide vaccination may represent a promising approach for tumour prevention in Lynch syndrome mutation carriers.</s></p><p><s>Interestingly, no mutations of the TGFBR2 coding microsatellite were observed in the present study, which is in contrast to our previous study <ref type="bibr" target="#b11">[12]</ref>, where TGFBR2 mutations were detected in larger polycryptic foci.</s><s>This discrepancy suggests that the occurrence of TGFBR2 mutations is restricted to large MMR-DCF that already show morphological alterations <ref type="bibr" target="#b11">[12]</ref>.</s><s>Hence, TGFBR2 mutations represent promising candidate alterations that might contribute to the progression of MMR-DCF towards malignant transformation of MMR-DCF.</s><s>Further studies are needed to validate this hypothesis.</s></p><p><s>To exclude technical reasons as factors underlying the observed alterations in MMR-DCF (e.g.</s><s>related to small amounts of template DNA or formalin fixation), we compared the mutation frequency of microsatellite markers in MMR-DCF and MMR-proficient mucosa from Lynch syndrome mutation carriers or MSS colorectal cancer patients.</s><s>The comparison revealed a low background rate of mutations.</s><s>The detection of significantly higher rates of mutations in MMR-DCF clearly argues in favour of MMR deficiency as a biological reason underlying the detected mutations.</s><s>Moreover, we were not able to confirm previous reports about a significantly higher prevalence of microsatellite mutations in normal mucosa from Lynch syndrome mutation carriers compared to MSS colorectal cancer control patients <ref type="bibr" target="#b37">[38]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>In summary, we here demonstrate for the first time that microsatellite instability is detectable in the vast majority of MMR-DCF, including monocryptic lesions.</s><s>Clinically, the occurrence of MMR-DCF in Lynch syndrome mutation carriers is significantly correlated to age, suggesting ongoing accumulation of MMR-DCF.</s><s>Coding microsatellite mutations were observed in mono-and poly-cryptic MMR-DCF, most frequently affecting HT001, AIM2 and BAX.</s><s>Mutations of the TGFBR2 gene appear to be restricted to polycryptic MMR-DCF, potentially suggesting that they may favour progression or malignant transformation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1. Histology and molecular phenotype of representative MMR-DCF.</s><s>(A) Staining of three representative MMR-DCF.</s><s>Objective magnification is 20x for all panels.</s><s>Representative staining results with antibodies specific for the MMR protein corresponding to the germline mutation of the respective patient.</s><s>Lesions are denoted by patient ID (LYS = Lynch syndrome patient) and lesion ID. (B) Fragment length analysis of triplex PCR with BAT25, BAT26 and CAT25.</s><s>Compared to two normal intestinal crypts analysed as a reference (lower panels), all three markers show deletion mutations in the examined MMR-DCF (LYS 21, Lesion 1).</s><s>Deletion mutations are indicated by red arrows in MMR-DCF (upper panel: BAT25, green peaks, -3; BAT26, filled blue peaks, -2; CAT25, open blue peaks, -1).</s><s>(C) Fragment length analysis of duplex PCR with BAX and HT001 of patient LYS 19.</s><s>Depiction of an HT001 (right sided fragments) mononucleotide shift (-1, red arrow) as an example of a coding microsatellite-bearing target gene mutation.</s><s>The fragment analysis is directly compared to the results obtained from two normal intestinal crypts of the same patient (lower panels).</s><s>doi:10.1371/journal.pone.0121980.g001</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. MMR-DCF prevalence and patient age.</s><s>Association between age (years) of the patient at operation and prevalence of MMR-DCF (A).</s><s>The association of MMR-DCF prevalence with patient age is depicted with a black line adjusted for a colon length of 15 cm; dots represent patients.</s><s>Estimated incident rate ratio of colorectal MMR-DCF was 1.75 (95% CI 1.30-2.35)</s><s>for a change of age at operation of 10 years.</s><s>The prevalence of MMR-DCF is not significantly associated with patients' gender (B) or the MMR gene affected by germline mutation (C).</s><s>doi:10.1371/journal.pone.0121980.g002</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. Distribution of mutation patterns within MMR-DCF.</s><s>Numbers of microsatellites mutated per MMR-DCF, separately shown for all markers (left panel), non-coding markers (middle: BAT25, BAT26, and CAT25), and coding markers (right panel: AIM2, ACVR2, BAX, HT001, TAF1B and TGFBR2) are separately shown.</s><s>The y-axis represents the percentage of MMR-DCF mutated, whereas the x-axis displays the numbers of microsatellites affected per lesion.</s><s>doi:10.1371/journal.pone.0121980.g003</s></p></div></figDesc><graphic coords="9,36.00,77.33,489.60,179.38" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 4 .</head><label>4</label><figDesc><div><p><s>Fig 4. Mutation frequency of microsatellite markers.</s><s>Black bars represent the observed mutation frequency of the respective microsatellites in MMR-DCF.</s><s>Mutation frequency reported in the literature for MSI-H colorectal adenoma and carcinoma are displayed by dark grey (adenoma) and white (carcinoma) bars, respectively.</s><s>Data for adenomas and carcinomas were retrieved from www.seltarbase.org.</s><s>Light grey bars indicate mutation frequency in corresponding carcinomas from the same patients from whom the MMR-DCF were obtained.</s><s>doi:10.1371/journal.pone.0121980.g004</s></p></div></figDesc><graphic coords="10,36.00,78.01,529.17,268.78" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>S1</head><label></label><figDesc><div><p><s>Fig. Immunohistochemical stains of MMR-DCF.</s><s>(A) Immunohistochemical stains of all initial MMR-DCF.</s><s>Overview of staining results with antibodies specific for the MMR protein corresponding to the germline mutation of the respective patient.</s><s>Lesions are denoted by patient ID and lesion ID.</s><s>All pictures were taken with a 20x magnification except for LYS 18 (Lesion 4) where a 10x magnification was used.</s><s>(B) Immunohistochemical stains of six additional MMR-DCF.</s><s>Lesions are denoted by patient ID and lesion ID and represent resectioning results of the respective patients.</s><s>For all pictures a 20x magnification was used.</s><s>(TIF) S2 Fig.</s><s>Combined overview of all 34 Lynch syndrome patients.</s><s>This diagram presents all 34 Lynch syndrome patients with patient ID,age at operation, tumour localisation and operation performed (SC = subtotal colectomy, RH = right hemicolectomy, LH = left hemicolectomy, AR = anterior rectum resection, SR = sigma resection and TR = total rectum resection).</s><s>Green</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | DOI:10.1371/journal.pone.0121980March 27, 2015  </note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We thank Beate Kuchenbuch and Petra Höfler for their excellent technical assistance.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Contributions</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>bars correspond to the primary x-axis displaying total numbers of MMR-DCF (first eleven patients).</s><s>Adjacent light blue (men) and light pink (women) bars indicate the measured mucosal length of the respective patient.</s><s>(TIF) S3 Fig. Regional diversity of MMR-DCF.</s><s>(A) Regional diversity in non-coding markers BAT25, BAT26 and CAT25.</s><s>The observed mutations varied widely between the six regions examined in this PCR approach for BAT25 (green), BAT26 (blue, filled) and CAT25 (blue).</s><s>na = not available.</s><s>BAT25: Region 1 (-3), Region 2 (-3), Region 3 (-3), Region 4 (wt), Region 5 (-2), Region 6 (-3).</s><s>BAT26: Region 1 (-4), Region 2 (-6), Region 3 (-3), Region 4 (-3), Region 5 (-3), Region 6 (-4).</s><s>CAT25: Region 1 (+3), Region 2 (+1), Region 3 (+2), Region 4 (na), Region 5 (wt), Region 6 (-1).</s><s>(B) Regional diversity in the coding marker HT001.</s><s>Regional diversity in the coding marker HT001 for one extensive crypt focus which was divided into six separately analysed regions.</s><s>The observed shift mutations were evaluated as follows: Region 1 (-1), Region</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Diagnosing Lynch syndrome: is the answer in the mouth?</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Lynch</surname></persName>
		</author>
		<idno type="PMID">14633939</idno>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1665" to="1667" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Boland CR Evolution of the nomenclature for the hereditary colorectal cancer syndromes</title>
		<idno type="PMID">16136380</idno>
	</analytic>
	<monogr>
		<title level="j">Fam Cancer</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="211" to="218" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Hereditary and familial colon cancer</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Jasperson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Tuohy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Neklason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Burt</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.gastro.2010.01.054</idno>
		<idno type="PMID">20420945</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="2044" to="2058" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer</title>
		<author>
			<persName><forename type="first">C</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rahner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schulmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Holinski-Feder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">O</forename><surname>Goecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Schackert</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cgh.2009.10.003</idno>
		<idno type="PMID">19835992</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="174" to="182" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Microsatellite instability</title>
		<author>
			<persName><forename type="first">A</forename><surname>De La Chapelle</surname></persName>
		</author>
		<idno type="PMID">12867603</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">349</biblScope>
			<biblScope unit="page" from="209" to="210" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Mutation and cancer: statistical study of retinoblastoma</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Knudson</surname><genName>Jr</genName></persName>
		</author>
		<idno type="PMID">5279523</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="820" to="823" />
			<date type="published" when="1971">1971</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Lindor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Burgart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Leontovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Goldberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Sargent</surname></persName>
		</author>
		<idno type="PMID">11844828</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1043" to="1048" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Thibodeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>French</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Roche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Tester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Lindor</surname></persName>
		</author>
		<idno type="PMID">8895729</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="4836" to="4840" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer</title>
		<author>
			<persName><forename type="first">G</forename><surname>Lindgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Liljegren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Jaramillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rubio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lindblom</surname></persName>
		</author>
		<idno type="PMID">11788565</idno>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="228" to="234" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC</title>
		<author>
			<persName><forename type="first">De</forename><surname>Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Morreau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Van Puijenbroek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Eilers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Wijnen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nagengast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="42" to="48" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2</title>
		<author>
			<persName><forename type="first">A</forename><surname>Liljegren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Barker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bertario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Bisgaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Eccles</surname></persName>
		</author>
		<idno type="DOI">10.1200/JCO.2007.13.2795</idno>
		<idno type="PMID">18612159</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="3434" to="3439" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kloor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Huth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Voigt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Benner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schirmacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Doeberitz</surname></persName>
		</author>
		<idno type="DOI">10.1016/S1470-2045(12)70109-2</idno>
		<idno type="PMID">22552011</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet Oncol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="598" to="606" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers</title>
		<author>
			<persName><forename type="first">A</forename><surname>Duval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rolland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Compoint</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tubacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Iacopetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Thomas</surname></persName>
		</author>
		<idno type="PMID">11181575</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="513" to="518" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Woerner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Benner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sutter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schiller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Keller</surname></persName>
		</author>
		<idno type="PMID">12700659</idno>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="2226" to="2235" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Woerner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Benner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Korff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Doeberitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bork</surname></persName>
		</author>
		<idno type="DOI">10.1093/nar/gkp839</idno>
		<idno type="PMID">19820113</idno>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="D682" to="689" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations</title>
		<author>
			<persName><forename type="first">D</forename><surname>Tougeron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fauquembergue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rouquette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Pessot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sesboue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Laurent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.1038/modpathol.2009.80</idno>
		<idno type="PMID">19503063</idno>
	</analytic>
	<monogr>
		<title level="j">Mod Pathol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1186" to="1195" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Schwitalle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Linnebacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ripberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Von Knebel Doeberitz</surname></persName>
		</author>
		<idno type="PMID">15563124</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Immun</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">14</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The landscape of microsatellite instability in colorectal and endometrial cancer genomes</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Laird</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Park</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2013.10.015</idno>
		<idno type="PMID">24209623</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page" from="858" to="868" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Woerner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kloor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Schwitalle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Youmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Doeberitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gebert</surname></persName>
		</author>
		<idno type="PMID">17726700</idno>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes Cancer</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1080" to="1089" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype</title>
		<author>
			<persName><forename type="first">N</forename><surname>Rampino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ionov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sawai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Reed</surname></persName>
		</author>
		<idno type="PMID">9020077</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="967" to="969" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ionov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Krajewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Reed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Perucho</surname></persName>
		</author>
		<idno type="PMID">10984511</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="10872" to="10877" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Inactivation of the type II TGFbeta receptor in colon cancer cells with microsatellite instability</title>
		<author>
			<persName><forename type="first">S</forename><surname>Markowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Myeroff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Parsons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lutterbaugh</surname></persName>
		</author>
		<idno type="PMID">7761852</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">268</biblScope>
			<biblScope unit="page" from="1336" to="1338" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Herman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Umar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Polyak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Graff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ahuja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Issa</surname></persName>
		</author>
		<idno type="PMID">9618505</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="6870" to="6875" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Simpkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bocker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Swisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Mutch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Gersell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Kovatich</surname></persName>
		</author>
		<idno type="PMID">10072435</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="661" to="666" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Mensenkamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">P</forename><surname>Vogelaar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Van Zelst-Stams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goossens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ouchene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Hendriks-Cornelissen</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.gastro.2013.12.002</idno>
		<idno type="PMID">24333619</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page">e648</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Differentiating Lynch-like from Lynch syndrome</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Carethers</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.gastro.2014.01.041</idno>
		<idno type="PMID">24468183</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="602" to="604" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Risk of cancer in cases of suspected lynch syndrome without germline mutation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rodriguez-Soler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Perez-Carbonell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guarinos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zapater</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Castillejo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Barbera</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.gastro.2013.01.044</idno>
		<idno type="PMID">23354017</idno>
	</analytic>
	<monogr>
		<title level="m">e921; quiz e913-924</title>
				<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="926" to="932" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The mystery of mismatch repair deficiency: lynch or lynch-like?</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Boland</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.gastro.2013.03.014</idno>
		<idno type="PMID">23523847</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="868" to="870" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The hallmarks of aging</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lopez-Otin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Blasco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Partridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Serrano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kroemer</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2013.05.039</idno>
		<idno type="PMID">23746838</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1194" to="1217" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Temozolomide Increases the Number of Mismatch Repair-Deficient Intestinal Crypts and Accelerates Tumorigenesis in a Mouse Model of Lynch Syndrome</title>
		<author>
			<persName><forename type="first">K</forename><surname>Wojciechowicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cantelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Van Gerwen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Plug</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Van Der Wal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Delzenne-Goette</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset</title>
		<author>
			<persName><forename type="first">H</forename><surname>Hampel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Stephens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pukkala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sankila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Aaltonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Mecklin</surname></persName>
		</author>
		<idno type="PMID">16083698</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="415" to="421" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome</title>
		<author>
			<persName><forename type="first">E</forename><surname>Stoffel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mukherjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Raymond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tayob</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kastrinos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sparr</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.gastro.2009.07.039</idno>
		<idno type="PMID">19622357</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="1621" to="1627" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Schwitalle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kloor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Eiermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Linnebacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kienle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Knaebel</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.gastro.2008.01.015</idno>
		<idno type="PMID">18395080</idno>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="988" to="997" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer</title>
		<author>
			<persName><forename type="first">I</forename><surname>Saeterdal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bjorheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lislerud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Gjertsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">K</forename><surname>Bukholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">C</forename><surname>Olsen</surname></persName>
		</author>
		<idno type="PMID">11687624</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="13255" to="13260" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<monogr>
		<title level="m" type="main">Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case. Fam Cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Shia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">K</forename><surname>Stadler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Weiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vakiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mendelsohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Markowitz</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">When does MMR loss occur during HNPCC progression?</title>
		<author>
			<persName><forename type="first">D</forename><surname>Shibata</surname></persName>
		</author>
		<idno type="PMID">17192057</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Biomark</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="29" to="35" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Colorectal pretumor progression before and after loss of DNA mismatch repair</title>
		<author>
			<persName><forename type="first">P</forename><surname>Calabrese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Tsao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yatabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Salovaara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Mecklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Jarvinen</surname></persName>
		</author>
		<idno type="PMID">15039232</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="page" from="1447" to="1453" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Mismatch repair deficiency in phenotypically normal human cells</title>
		<author>
			<persName><forename type="first">R</forename><surname>Parsons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Longley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Modrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Berk</surname></persName>
		</author>
		<idno type="PMID">7632227</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">268</biblScope>
			<biblScope unit="page" from="738" to="740" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
